StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioCorRx's price to sales ratio was 3.5× on Jan 30, 2026, against 126.4× a year earlier. Over the last 5 years it ranged from 3.4× to 498.0×, with a median of 97.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20263.5×+0.1
2025Dec 31, 20253.4×−156.7
2024Dec 31, 2024160.2×+128.8
2023Dec 29, 202331.3×−109.1
2022Dec 30, 2022140.5×−191.3
2021Dec 31, 2021331.8×+300.2
2020Dec 31, 202031.6×−31.9
2019Dec 31, 201963.5×+35.1
2018Dec 31, 201828.4×−37.9
2017Dec 29, 201766.4×+58.7
2016Dec 30, 20167.7×+4.2
2015Dec 31, 20153.5×−6.5
2014Jan 31, 201410.0×+0.8
2013Dec 31, 20139.3×+7.2
2012Dec 31, 20122.0×–

More BioCorRx figures

See a number that looks wrong?